Formal Patient Education Improves Patient Knowledge of Hepatitis C in Vulnerable Populations

Overview

Journal Dig Dis Sci

Specialty Gastroenterology

Date 2010 Oct 26

PMID 20972850

Citations 39

Authors

Miranda Surjadi

Cara Torruellas

Claudia Ayala

Hal F Yee Jr

Mandana Khalili

Affiliations

Soon will be listed here.

Abstract

Background: Hepatitis C (HCV) knowledge is limited in injection drug users (IDU). Vulnerable populations including IDUs are disproportionally affected by HCV. Effective HCV education can potentially reduce disparity in HCV prevalence and its outcome in this population.

Aim: This study aimed to assess the impact of formal HCV education and factors associated with improved HCV knowledge in the vulnerable population.

Methods: Over 18 months, 201 HCV-infected patients underwent a 2-h standardized education and completed demographic and pre- and post-education questionnaires.

Results: Patient characteristics were: 69% male, mean age 49±10, 49% White (26% AA, 10% Latino), 75% unemployed, 83% high school education and above, 64% were IDU, and 7% were HIV co-infected. On multivariate analysis, baseline knowledge scores were higher in patients with at least a high school education (coef 7.1, p=0.045). Baseline knowledge scores were lower in African Americans (coef -12.3, p=0.004) and older patients (coef -0.7, p=0.03). Following HCV education, the overall test scores improved significantly by 14% (p=0.0001) specifically in the areas of HCV transmission (p=0.003), general knowledge (p=0.02), and health care maintenance (p=0.004). There was a high compliance with liver specialty clinic attendance following education.

Conclusions: Formal HCV education is effective in improving HCV knowledge. Although White race, younger age, and higher education were predictors of having more HCV knowledge prior to education, all patients independent of racial background had a significant improvement in their knowledge after education. Therefore, promoting effective HCV education among vulnerable populations may be an important factor in reducing the disparities in HCV disease.

Citing Articles

Steatotic Liver Disease Education Enhances Knowledge and Confidence to Adhere to Provider Recommendations in Diverse and Vulnerable Populations.

Patel S, Partida D, Magee C, Garza Romero F, Chen J, Tana M Gastro Hep Adv. 2025; 4(3):100589.

PMID: 39931048 PMC: 11808611. DOI: 10.1016/j.gastha.2024.11.005.

Fatty Liver Education Promotes Physical Activity in Vulnerable Groups, Including Those With Unhealthy Alcohol Use.

Patel S, Kim R, Shui A, Magee C, Lu M, Chen J Gastro Hep Adv. 2024; 3(1):84-94.

PMID: 39100862 PMC: 11293529. DOI: 10.1016/j.gastha.2023.09.012.

HEPATITIS C PSYCHOEDUCATION CURRICULUM TOPICS GENERATED BY GROUP MEMBERS.

Pollio D, North C, Sims O, Hong B Soc Work Groups. 2024; 44(1):83-90.

PMID: 38274393 PMC: 10810246. DOI: 10.1080/01609513.2020.1815631.

Telehepatology Satisfaction Is Associated with Ethnicity: The Real-World Experience of a Vulnerable Population with Fatty Liver Disease.

Kim R, Patel S, Satre D, Shumway M, Chen J, Magee C Dig Dis Sci. 2024; 69(3):732-742.

PMID: 38217682 PMC: 10960743. DOI: 10.1007/s10620-023-08222-7.

Efficacy of a Primary Care-Based Mobile Application to Increase Hepatitis C Screening Among Asian Americans: A Secondary Analysis of a Randomized Clinical Trial.

Khalili M, Kim N, Tsoh J, Walsh J, Elizabeth Goldman L, Park H Open Forum Infect Dis. 2023; 10(1):ofad002.

PMID: 36726551 PMC: 9887262. DOI: 10.1093/ofid/ofad002.

References

M Ferrante J, Winston D, Chen P, de la Torre A . Family physicians' knowledge and screening of chronic hepatitis and liver cancer. Fam Med. 2008; 40(5):345-51. View

Chitwood D, McBride D, French M, Comerford M . Health care need and utilization: a preliminary comparison of injection drug users, other illicit drug users, and nonusers. Subst Use Misuse. 1999; 34(4-5):727-46. DOI: 10.3109/10826089909037240. View

Beste L, Straits-Troster K, Zickmund S, Larson M, Chapko M, Dominitz J . Specialty care and education associated with greater disease-specific knowledge but not satisfaction with care for chronic hepatitis C. Aliment Pharmacol Ther. 2009; 30(3):275-82. DOI: 10.1111/j.1365-2036.2009.04036.x. View

Balfour L, Cooper C, Tasca G, Kane M, Kowal J, Garber G . Evaluation of health care needs and patient satisfaction among hepatitis C patients treated at a hospital-based, viral hepatitis clinic. Can J Public Health. 2004; 95(4):272-7. PMC: 6975576. View

Gupta K, Romney D, Briggs M, Benker K . Effects of a brief educational program on knowledge and willingness to accept treatment among patients with hepatitis C at inner-city hospitals. J Community Health. 2007; 32(4):221-30. DOI: 10.1007/s10900-007-9046-8. View

Munoz-Plaza C, Strauss S, Astone-Twerell J, Des Jarlais D, Gwadz M, Hagan H . Exploring drug users' attitudes and decisions regarding hepatitis C (HCV) treatment in the U.S. Int J Drug Policy. 2008; 19(1):71-8. PMC: 2698452. DOI: 10.1016/j.drugpo.2007.02.003. View

Strauss E . Barriers to care of chronic hepatitis patients in Latin America. Arch Med Res. 2007; 38(6):711-5. DOI: 10.1016/j.arcmed.2007.02.002. View

OBrien S, Day C, Black E, Dolan K . Injecting drug users' understanding of hepatitis C. Addict Behav. 2008; 33(12):1602-5. DOI: 10.1016/j.addbeh.2008.07.005. View

Armstrong G, Wasley A, Simard E, McQuillan G, Kuhnert W, Alter M . The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006; 144(10):705-14. DOI: 10.7326/0003-4819-144-10-200605160-00004. View

10.

Doab A, Treloar C, Dore G . Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia. Clin Infect Dis. 2005; 40 Suppl 5:S313-20. DOI: 10.1086/427446. View

11.

Walley A, White M, Kushel M, Song Y, Tulsky J . Knowledge of and interest in hepatitis C treatment at a methadone clinic. J Subst Abuse Treat. 2005; 28(2):181-7. DOI: 10.1016/j.jsat.2004.12.004. View

12.

Minuk G, Gutkin A, Wong S, Kaita K . Patient concerns regarding chronic hepatitis C infections. J Viral Hepat. 2005; 12(1):51-7. DOI: 10.1111/j.1365-2893.2005.00553.x. View

13.

Nelson A . Unequal treatment: confronting racial and ethnic disparities in health care. J Natl Med Assoc. 2002; 94(8):666-8. PMC: 2594273. View

14.

Groessl E, Weingart K, Kaplan R, Clark J, Gifford A, Ho S . Living with hepatitis C: qualitative interviews with hepatitis C-infected veterans. J Gen Intern Med. 2008; 23(12):1959-65. PMC: 2596521. DOI: 10.1007/s11606-008-0790-y. View

15.

Fabris P, Tositti G, Giordani M, Baldo V, Grasso A, Pignattari E . Assessing patients' understanding of hepatitis C virus infection and its impact on their lifestyle. Aliment Pharmacol Ther. 2006; 23(8):1161-70. DOI: 10.1111/j.1365-2036.2006.02882.x. View

16.

Strauss S, Falkin G, Vassilev Z, Des Jarlais D, Astone J . A nationwide survey of hepatitis C services provided by drug treatment programs. J Subst Abuse Treat. 2002; 22(2):55-62. DOI: 10.1016/s0740-5472(01)00213-6. View

17.

Strauss S, Astone-Twerell J, Munoz-Plaza C, Des Jarlais D, Gwadz M, Hagan H . Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services. BMC Health Serv Res. 2007; 7:39. PMC: 1831471. DOI: 10.1186/1472-6963-7-39. View